Evidence mapPaperPMID 37206362Full record

ArticleFrontiers in physiology2023

Advanced lung cancer inflammation index is associated with long-term cardiovascular death in hypertensive patients: national health and nutrition examination study, 1999-2018.

Jiabin Tu, Bo Wu, Jiaming Xiu, Jiayi Deng, Shuqiong Lin, Jin Lu, Yanfang Yan, Pei Yu, Jinlong Zhu, Kaihong Chen and 2 more

Abstract read
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Role of Advanced Lung Cancer Inflammation Index in Predicting COPD Exacerbation Risks.International journal of chronic obstructive pulmonary disease · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiabin TuLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Bo WuLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Jiaming XiuLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Jiayi DengLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Shuqiong LinZhangzhou Affiliated Hospital to Fujian Medical University, Zhangzhou, China.
Jin LuLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Yanfang YanLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Pei YuLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Jinlong ZhuLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Kaihong ChenLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Shan DingZhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Liling ChenLongyan First Affiliated Hospital of Fujian Medical University, Longyan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced lung cancer inflammation indexcardiovascular deathhypertensioninflammationNHANES

Identifiers

PMID37206362
PMCPMC10189044

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.